CARRIE DURANTE: Open Payments
NPI 1114299484 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,921 in 100 payments from 16 companies in 2025. Trend: 2023 $1,569 · 2024 $2,116 · 2025 $1,921
Food & beverage: $1,921
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $517 |
| Janssen Biotech, Inc. | 14 | $227 |
| Regeneron Healthcare Solutions, Inc. | 5 | $178 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $169 |
| Aimmune Therapeutics, Inc. | 6 | $151 |
| Phathom Pharmaceuticals, Inc. | 11 | $149 |
| Enterra Medical, Inc. | 2 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $112 |
| Ardelyx, Inc. | 3 | $70 |
| Celltrion USA Inc. | 3 | $63 |
Products named: RINVOQ, TREMFYA, ZENPEP, VOQUEZNA, XIFAXAN, ENTYVIO, CREON, DUPIXENT.
Industry payments across TN — which companies pay providers there.
